30
Mar
IASO Bio Publicizes NMPA’s IND Acclaim for Equecabtagene Autoleucel in Second-Line Therapy of Just a few Myeloma, Industry Info
Business new tamfitronics /PRNewswire/ -- IASO Bio, a biopharmaceutical firm engaged in discovering, constructi...